Furthermore, to promote their clinical application, our DC can be loaded with different kinds of tumor antigens and since the expansion and survival effects of IL-15 on CTLs are antigen-independent [47], our DC vaccine can be used against a broad range of tumor types. Here, IL15 is linked to neoplasm.